ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO333

Measuring Mindset: Validation of the Health Mindset Scale (HMS) in Peritoneal Dialysis (PD) Patients

Session Information

  • Home Dialysis - I
    November 02, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis

Authors

  • Fissell, Rachel B., Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Patel, Sagar, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Gupta, Nupur, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Taber-Hight, Elizabeth, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Bansal, Shweta, University of Texas Health Sciences Center, San Antonio, Texas, United States
  • Nair, Devika, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Umeukeje, Ebele M., Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Guide, Andrew, Vanderbilt University, Nashville, Tennessee, United States
  • Wild, Marcus G., Vanderbilt University, Nashville, Tennessee, United States
  • Mueller, Claudia, Stanford University School of Medicine, Stanford, California, United States
  • Greevy, Robert, Vanderbilt University, Nashville, Tennessee, United States
  • Cavanaugh, Kerri L., Vanderbilt University Medical Center, Nashville, Tennessee, United States
Background

Many patients who start peritoneal dialysis (PD) transition to hemodialysis after complications. Patient psychological factors may influence long-term PD success. Fixed mindset is the belief that ability cannot change, and growth mindset is the belief that knowledge and ability can grow and improve. Patient mindset may influence PD training, patient dialysis task execution at home, patient response to peritonitis, and modality persistence. The purpose of this study is to examine validity of the Health Mindset Scale (HMS) among adult PD patients.

Methods

Home dialysis units at two academic medical centers in the US are participating. The Health Mindset Scale (HMS), a 3-item Likert-based survey [scored 3-18, higher number indicates greater growth mindset], was administered at baseline, and then repeated for test-retest reliability. Instruments for resilience, depression, and health mindset specific to peritonitis were also administered at baseline. Spearman's rank correlation coefficients assessed correlations, and Cronbach's alpha assessed internal consistency.

Results

Mean age of 52 enrolled participants was 52yo [SD 16], with 48% male, 28% black, 40% with diabetes, and 87% with hypertension. Mean vintage was 628 days [SD 631]. Mean albumin was 3.9 gm/dL [SD 0.44]. Mean HMS score was 11.8 [SD 4.9] at baseline, and 13.7 [SD 3.5] at follow-up. HMS test-retest correlation was 0.43 [95% CI 0.05, 0.70]. Correlations between HMS and peritonitis mindset score, resilience, and depression were 0.64 [95% CI 0.41, 0.79], 0.26 [95% CI -0.03, 0.50], and 0.13 [95% CI -0.16, 0.40], respectively. Cronbach's alphas for baseline HMS, peritonitis mindset, depression, and resilience were 0.88, 0.83, 0.69, and 0.93, respectively.

Conclusion

Results results suggest good internal consistency of instruments for health mindset and peritonitis mindset, depression, and resilience in this sample of adult PD patients. Mindset variation suggests that an intervention to support growth mindset may be an important target to maintain PD as the ESKD treatment option.

Funding

  • Private Foundation Support